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The polarized trafficking of membrane proteins into the
leading edge of the cell is an integral requirement for
cell migration. Myosin VI and its interacting protein
optineurin have previously been shown to operate
in anterograde trafficking pathways, especially for the
polarized delivery of cargo to the basolateral domain in
epithelial cells. Here we show that in migratory cells
ablation of myosin VI or optineurin inhibits the polarized
delivery of the epidermal growth factor receptor (EGFR)
into the leading edge and leads to profound defects
in lamellipodia formation. Depletion of either myosin
VI or optineurin, however, does not impair the overall
ability of cells to migrate in a random migration assay,
but it dramatically reduces directed migration towards
a growth factor stimulus. In summary, we identified a
specific role for myosin VI and optineurin in directionally
persistent cell migration, which involves the polarized
delivery of vesicles containing EGFR into the leading
edge of the cell.
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Migration is a fundamental cellular activity that is crucial for
a wide range of cellular events that includes embryonic
development, wound healing, inflammation and cancer
cell dissemination and metastasis. Cell membrane protru-
sion at the leading edge and subsequent migration involve
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a complex set of processes initiated by extracellular sig-
nals that trigger regulated actin remodelling at the plasma
membrane together with endocytic/exocytic membrane
delivery. To initiate forward migration, the cell polarizes
along the axis of movement and forms protrusions at
its leading edge. These protrusions are stabilized by the
assembly of cell-substrate adhesion sites, whereas at the
trailing rear end of the cell actomyosin II-dependent con-
traction releases these adhesions and drives the cell body
forward (1). The formation of membrane protrusions at the
leading edge is dependent on actin filament polymerization
that is regulated by the Arp2/3 complex and the Rho fam-
ily of small GTPases; e.g. Rac mediates the formation of
broad lamellipodia, whereas cdc42 activation induces cell
polarization and filopodia (2). This localized actin filament
network formation together with substrate adhesion is
part of the basic machinery that drives random cell migra-
tion. Although the mechanism of random cell migration
has been studied in great detail, far less is known about the
complex system of regulation that controls directionally
persistent migration (3). Directed migration, which can be
triggered by extracellular stimuli such as the topography
of the extracellular matrix or by a growth factor gradient, is
controlled amongst other factors by polarized signalling at
the leading edge. The spatial restriction of signalling recep-
tors and pathways at the leading edge stabilizes selected
lamellipodia and thereby maintains the orientation and
direction of movement (3).
It is now widely accepted that the delivery of plasma
membrane components and cell surface receptors to the
leading edge via anterograde membrane trafficking path-
ways is important for lamellipodia extension. Exocytosis
of vesicles not only from the endocytic recycling com-
partment is essential for cell locomotion (4,5) but also the
polarized delivery of newly synthesized proteins from the
Golgi complex into the leading edge is required for cell
polarization and persistent migration (6–8).
In this study, we have focused on the potential role(s)
of myosin VI in mammalian cell locomotion. Myosin VI is
a unique member of the myosin superfamily, because it
moves towards the minus end of actin filaments, in the
opposite direction to all other characterized myosins (9).
This reverse movement is mediated by a unique 53-amino
acid insertion (reverse gear) between the converter region
in the motor domain and the neck (lever-arm) region.
Myosin VI is ubiquitously expressed in higher eukary-
otic cells, where it has been linked to a wide variety
of different intracellular functions. In Drosophila, myosin
VI is required for various membrane remodelling pro-
cesses during embryogenesis, suggesting potential roles
for myosin VI in cell motility such as in epithelial cell
1290 www.traffic.dk
Myosin VI and Optineurin in Cell Migration
migration during dorsal closure in the embryo (10). Fur-
thermore, in Drosophila ovaries myosin VI is involved in
border cell migration, where it interacts and stabilizes β-
catenin/E-cadherin adhesion complexes and may also be
linked to the formation of membrane protrusions at the
leading edge of these moving cells (11).
In mammalian cells, myosin VI plays important roles
in endocytic and exocytic membrane trafficking path-
ways (12–14) as well as in cadherin-based cell–cell con-
tact morphogenesis (15). A number of adaptor molecules
have been identified that link myosin VI to different
intracellular cargoes associated with specific intracellular
functions. For example, myosin VI’s function in clathrin-
mediated endocytosis at the plasma membrane is medi-
ated by Disabled-2 (Dab2) (16) and the phosphoinositide
PIP2 Phosphatidylinositol 4,5-bisphosphate (17), whereas
GAIP-interacting protein C-terminus (GIPC) (18) and the
Ser/Thr transmembrane protein kinase LMTK2 (19) recruit
myosin VI to endosomes and the recycling pathway.
Recently, GIPC and myosin VI have been linked to α5β1
integrin trafficking (20), suggesting a role for myosin VI in
focal adhesion turnover. In addition, myosin VI together
with another of its interacting proteins optineurin performs
an important role in the secretory pathway for the delivery
of cargo from the Golgi complex to the plasma mem-
brane (14,21). Furthermore, in polarized epithelial cells
myosin VI and optineurin are required for the sorting of
newly synthesized proteins specifically to the basolateral
but not to the apical domain (22). In these cells, myosin
VI and optineurin can be found on recycling endosomes,
which are an important sorting station for cargo en route
to the basolateral domain (22,23). Sorting of cargo emerg-
ing from the trans Golgi network and delivery to distinct
plasma membrane domains not only occurs in epithelial
cells but has also been described for motile cells (24–26).
In migrating fibroblasts, proteins with basolateral sorting
motifs are transported into the leading edge, whereas in
non-motile cells this transport polarity is lost and secre-
tory vesicles are delivered randomly to the entire plasma
membrane.
Here, we have investigated the molecular mechanism and
the potential roles of myosin VI and its binding partners in
cell migration. We conclusively show that myosin VI and
its interacting protein optineurin are required for the polar-
ized delivery of epidermal growth factor receptor (EGFR)
into the leading edge and that the loss of either myosin
VI or optineurin leads to severe defects in protrusion for-
mation. We further show that both proteins are essential
for growth factor-stimulated directionally persistent migra-
tion, but are not components of the basic machinery that
drives random cell migration. Thus, our results indicate
that the role of myosin VI in cell migration is directly linked
to optineurin and both proteins are required for the delivery
of cargo into the leading edge so as to control the spa-
tial distribution of signalling receptors and cell adhesion
molecules that are important for the directed movement
of cells.
Results
Myosin VI is required for lamellipodia and ruffle
formation at the leading edge of cells
The leading edge of a motile cell contains membrane pro-
trusions that are formed by actin filament polymerization
together with polarized vesicle trafficking (2,27). Myosin
VI is enriched in those regions of the plasma membrane
in the leading edge that exhibit active lamellipodial
protrusions, which characteristically contain membrane
ruffles (28).
In this article, we have studied the potential role of myosin
VI at the leading edge by investigating the migratory
behaviour of cells depleted of myosin VI. We first exam-
ined whether myosin VI is required for lamellipodia forma-
tion/ruffling during mammalian cell migration. To induce
synchronizedmigration and protrusion formation, a wound
was scratched into a confluent layer of HeLa cells, which
had been transfected with control or myosin VI siRNA
smart pool oligos. Control HeLa cells extended a broad,
flat lamellipodium,whereas inmyosin VI-depleted cells the
lamellipodium is lost and replaced by long finger-like pro-
trusions extending into the open wound area (Figure 1A).
Identical results were obtained, when myosin VI functions
were inhibited by overexpressing the dominant-negative
myosin VI tail domain, i.e. missing the functional motor
domain. This approach has been previously shown to
inhibit myosin VI-dependent processes in the endocytic
pathway and during cytokinesis (12,13,29). HeLa cells
overexpressing fully functional full-length green fluores-
cent protein (GFP)-tagged myosin VI extend broad mem-
brane protrusions at the base of the cell, whereas in cells
overexpressing GFP-myosin VI tail there are less lamel-
lipodia and more filopodia emerging into the wound space
(Figure 1B).
These results, showing that myosin VI is required for
lamellipodia extension and ruffle formation in HeLa cells,
were confirmed and quantified in more motile cells,
namely A549, the human lung adenocarcinoma epithelial
cell line, which extend very prominent lamellipodia that
are covered in dorsal ruffles (Figure 1C). These A549 cells
were transfected with either control oligonucleotides,
smart pool siRNA-targeting myosin VI or with four
single oligos specific for myosin VI. A scratch wound
was made in a confluent layer of cells and after 1 h
the cells were fixed and stained for F-actin. Whereas
control A549 cells extend very prominent lamellipodia
into the wound (Figure 1C), considerably less of these
types of extensions were visible in myosin VI-depleted
cells. We counted cells extending large lamellipodia with
ruffles into the wound and observed a more than 50%
decrease in the ability of myosin VI knockdown (KD)
cells to form lamellipodia with ruffles compared to control
cells (Figure 1D). Reassuringly, the four single siRNA
oligos targeting myosin VI gave a very similar reduction
in the number of lamellipodia as compared with cells
depleted by the smart pool siRNA (Figure 1D). Thus, in
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Figure 1: Inhibition ofmyosin VI
function results in loss of lamel-
lipodia and ruffle formation in
HeLa and A549 cells. A) Con-
trol or myosin VI siRNA-treated
HeLa cells and (B) HeLa cells sta-
bly expressing GFP-myosin VI or
GFP-myosin VI tail were grown
to confluence, wounded, left to
recover for 2 h, then fixed and
stained with fluorescently labelled
phalloidin. Images represent con-
focal Z projections. Arrows indi-
cate lamellipodia. Bar, 10 μm. C)
A549 cells were transfected with
control siRNA or either the smart
pool siRNA or four different single
siRNA oligos specific to myosin
VI. The cells were grown to con-
fluence, wounded, left to recover
for 1 h, then fixed and stained with
fluorescently labelled phalloidin to
label F-actin. Shown is a repre-
sentative picture of fixed cells
at the wound edge. Bar, 10 μm.
D) Quantification of the number
of control or myosin VI-depleted
A549 cells that extend large lamel-
lipodia with extensive ruffles into
the open area. Values shown are
means ± SD from six indepen-
dent siRNA experiments (for con-
trol and myosin VI smart pool) or
means ± range from two indepen-
dent siRNA experiments (for single
oligos).
the absence of functional myosin VI, which was depleted
either by overexpression of the dominant-negative tail
or by siRNA-mediated KD using smart pool siRNA or
four single oligos, there is a dramatic reduction in the
ability of cells to extend lamellipodia at a scratch wound
edge.
The overall protrusion activity at the plasma
membrane is reduced in myosin VI-depleted cells
The loss of myosin VI results in a dramatic reduction
in the number of A549 cells that are able to extend a
large lamellipodium with dorsal ruffles into the space of a
scratch wound. The presence or absence of these large
lamellipodia was quantified at a single time-point 1 h after
applying the scratch wound (Figure 1D). To visualize the
overall membrane dynamics, including smaller protrusion
activity at the leading edge facing the wound, A549 cells
were analysed by time-lapse microscopy. An example
of a large lamellipodium (>5 μm on average) that was
used to quantify ruffling activity (Figure 1D) is shown in
Figure 2A. These large membrane protrusions are present
for at least half an hour and show intensive ruffling activity,
as can be seen from the corresponding kymograph. We
did not observe any significant differences in their overall
dynamics such as e.g. their lifetime, which could have
explained the reduction in the total number of these large
lamellipodia that were detected in fixed cells depleted
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Figure 2: Depletion of myosin VI
affects membrane dynamics at
the leading edge. A) A single
frame from a corresponding time-
lapse video showing a large lamel-
lipodia at the leading edge of con-
trol A549 cell. The image on the
right is a kymograph generated from
the corresponding video. The vertical
white line indicates the area used to
generate the kymograph. Ascending
contours correspond to membrane
protrusion, descending contours cor-
respond to membrane retraction and
dark lines indicate membrane ruf-
fling. B) Leading edge dynamics of
control and myosin VI siRNA-treated
cells. The images on the left rep-
resent single frames from corre-
sponding time-lapse series (Videos
S1 and S2). Images on the right are
kymographs generated from the cor-
responding videos. C) Quantification
of lamellipodia length. Values shown
are means ± SD from 30 lamellipo-
dia from at least 10 cells for each
condition.
of myosin VI. However, thorough analysis of the leading
edge of the cells facing the wound revealed that depletion
of myosin VI leads to a dramatic decrease in the overall
protrusion activity of the plasma membrane, which can
only be visualized by time-lapsemicroscopy (Figure 2B and
Videos S1 and S2). As can be seen from the kymographs,
myosin VI-depleted cells exhibit less plasma membrane
fluctuations at the edge of the cell and less membrane
ruffles. Comparing the dynamics of smaller lamellipodia
protrusions in control and myosin VI KD cells revealed that
they had similar lifetimes and protrusion velocities, but
the lamellipodia lengths were slightly shorter in myosin
VI-depleted cells (Figure 2C). These results indicate that
myosin VI is involved in the initiation of lamellipodia
protrusion.
Loss of the myosin VI-interacting protein optineurin
reduces lamellipodia formation
The intracellular functions of myosin VI are mediated
by interacting adaptor proteins, which target myosin
VI to different cellular locations and cargoes. Binding
partners such as GIPC, Dab2 and LMTK2 link myosin VI
to the endocytic pathway, whereas optineurin mediates
myosin VI’s role in the biosynthetic secretory pathway. To
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Figure 3: The myosin VI-
interacting protein optineurin
is required for lamellipodia and
ruffle formation as well as for
macropinocytosis in A549 cells.
A549 cells were transfected with
control siRNA or siRNA specific
to myosin VI, GIPC, optineurin,
LMTK2 or Dab2. Two days after
the second transfection, the cells
were processed for assays. A)
A confluent layer of cells was
wounded to induce protrusion
formation. The graph represents
the quantification of the number
of cells that extend large lamel-
lipodia with extensive ruffles into
the wound. Values shown are
means ± SD from six indepen-
dent siRNA experiments. B) To
assess lamellipodia formation in
the presence of cycloheximide,
control or myosin VI knockdown
cells were incubated for 2 h in
50 g/ml of cycloheximide, before
the confluent layer of cells was
wounded to induce lamellipodia
formation in the presence of
cycloheximide. C) Western blot
of siRNA knockdown experiment
with antibodies to optineurin,
myosin VI, LMTK2, Dab2 and
GIPC. D) A representative picture
of fixed control and optineurin
knockdown cells at the wound
edge. Bar, 10 μm. E) To assess
macropinocytosis control, myosin
VI or optineurin knockdown cells
were incubated with 70-kDa
dextran and the number of
cells containing dextran-positive
structures larger than 0.5 μm in
size were counted. Values shown
are means ± SD from three
independent siRNA experiments.
determine which of these binding partners are required in
the process of leading edge protrusion and cell migration,
we transfected A549 cells with siRNAs specific for GIPC,
optineurin, Dab2, LMTK2 or myosin VI and analysed their
ability to extend lamellipodia with dorsal ruffles into a
scratch wound (Figure 3A). We observed in cells with
reduced expression levels of optineurin a 50% reduction
in the number of cells extending lamellipodia into the
scratch wound. A very similar inhibition of protrusion
formation was present in myosin VI KD cells (Figures 1D
and 3A). The loss of Dab2 or LMTK2, however, resulted
only in a slight drop in lamellipodia formation, whereas in
contrast the absence of GIPC did not cause a loss but an
increase in the number of cells with lamellipodia at the
leading edge (Figure 3A). Even a double KD of Dab2/GIPC,
Dab2/LMTK2 or GIPC/LMTK2 did not inhibit protrusion
formation indicating that these binding partners involved in
endocytic pathways are unlikely to play partially redundant
roles in lamellipodia formation (Figure S1A,B). Overall, only
the loss of optineurin leads to very similar changes in cell
morphology and the absence of lamellipodia extending
into the wound as observed in myosin VI KD cells (cf.
Figure 1C and Figure 3D). This phenotype is mimicked
by the protein synthesis inhibitor cycloheximide, which
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also causes a 50% inhibition of protrusion formation in
control cells. No additional effect was observed in myosin
VI KD cells when cycloheximide was added (Figure SB),
suggesting that the loss of leading edge protrusions in
myosin VI KD cells must be linked to defects in the
secretory pathway. Interestingly, the GTPase Rab8, which
has been shown to bind to optineurin (30), is not required
for protrusion formation (Figure S1A,B).
Membrane ruffles are not only linked to cell motility but
are also essential for macropinocytosis, a specialized
endocytic pathway that enables the cell to internalize
large amounts of fluid from the external environment.
Macropinosomes are induced by growth factors and
are formed when a circular ruffle closes or folds back
onto itself. As macropinosomes are strictly dependent
on membrane ruffles, we assessed macropinocytosis
in myosin VI and optineurin-depleted cells. The cells
were incubated with 70-kDa dextran and the number
of cells containing dextran-positive structures larger than
0.5 μm in size was counted. As shown in Figure 3E, the
loss of myosin VI or optineurin in A549 cells causes a
reduction in the number of cells that have internalized
macropinosomes. These results indicate that myosin VI
and optineurin are involved in the formation of large sheet-
like membrane protrusions and membrane ruffles that are
linked to cell motility and macropinocytosis.
Myosin VI and optineurin are required for polarized
delivery of EGFR into the leading edge
In a migrating cell, secretory vesicles are delivered
preferentially towards the leading edge by a process that
requires intact microtubules (7) and the positioning of the
pericentrosomal Golgi ribbon towards the wound edge (8).
In these studies after depolymerization of microtubules or
dispersal of Golgi membranes from their pericentrosomal
position, normal secretion kinetics were maintained, but
the polarized delivery towards the leading edge was lost
and defects in directionally persistent migration were
observed. As myosin VI and the optineurin-interacting
protein Rab8 have been shown to be required for polarized
delivery of cargo to the basolateral domain in epithelial
cells and towards the synapse in neurons (22,31–33),
we tested whether the loss of myosin VI or optineurin
affects directed secretion of newly synthesized proteins
towards the leading edge. We investigated the localization
of EGFR, a receptor tyrosine kinase, in control and KD
A549 cells at the edge of a scratch wound. In this cell
type, the EGFR is concentrated in membrane protrusions
extended into the wound edge, thereby generating a
spatial distribution of the receptor supporting localized
RTK signalling so as to produce directed cell migration.
The concentration of EGFR in lamellipodia can be detected
with a monoclonal antibody to the receptor (Figure 4)
and also by incubating the cells for short times (<5 min)
with fluorescently labelled epidermal growth factor (EGF)
Figure 4: Myosin VI and optineurin
are required for polarized secretion
of EGFR into the leading edge. A549
cells were transfected with control
siRNA or siRNA specific to myosin VI
or optineurin. The cells were grown to
confluence, wounded, left to recover
for 1 h, then fixed and processed for
immunofluorescence with monoclonal
antibody to EGFR and fluorescently
labelled phalloidin to label F-actin.
Merged colour images are shown in the
right-hand panel. The images presented
are confocal slices through the base of
the cells. Bar, 10 μm.
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Figure 5: Loss of myosin VI or
optineurin leads to the absence of
EGFR from the plasma membrane
facing the wound edge. A549 cells
were transfected with control siRNA
or siRNA specific to myosin VI or
optineurin. A confluent layer of cells
was wounded, left to recover for 1 h,
incubated with 250 ng/mL Alexa 488-
labelled EGF for 3 min, then fixed and
stained with fluorescently labelled phal-
loidin to label F-actin. Merged colour
images are shown in the right-hand
panel. The images presented are confo-
cal slices through the base of the cells.
Bar, 10 μm.
(Figure 5). Taken together, both assays indicate that active
receptor, which is able to bind EGF, is enriched in
membrane protrusion in this cell type (Figures 4 and 5).
In the absence of myosin VI or optineurin, however, we
observe a dramatic change in the polarized distribution
of EGFR at the cell surface lining the wound edge. We
specifically detected a loss of EGFR from the plasma
membrane facing the wound, but in contrast there was
no obvious reduction in the amount of EGFR on the rest
of the cell surface such as on lateral membranes that are
in contact with neighbouring cells (Figures 4 and 5). This
observation was confirmed by fluorescence-activated cell
sorter (FACS) analysis, which showed that there was no
difference in the amount of EGFR on the total surface
of control or KD cells (Figure 6A). Taken together, these
results indicate that myosin VI and optineurin are required
for the polarized delivery, i.e. the directed secretion of
EGFR into the leading edge but not for steady-state
exocytosis of these membrane proteins. Interestingly,
in myosin VI and optineurin KD cells, but not in control
cells, we detected an accumulation of small vesicles in
the cytoplasm using a monoclonal antibody to the EGFR
(13A9, Genentec) (Figures 4 and S2). This antibody has
been reported to bind to both the occupied and empty
EGFR (34) and therefore is able to recognize the receptor
in the biosynthetic pathway, before it reaches the cell
surface. These small EGFR-containing vesicles are not
labelled after endocytosis of Alexa 488-EGF, which further
confirms the biosynthetic nature of this compartment
(Figure S3). In optineurin KD cells, we observed that
these EGFR-containing vesicles can cluster into larger
aggregates (Figures S2 and S3). To further characterize
the nature of these EGFR-containing vesicles in myosin
VI KD cells, double labelling experiments were performed
with antibodies to marker proteins of the early and late
endocytic pathways such as vps26 (retromer complex),
cathepsin D and mannose-6-phosphate receptor. None of
these marker proteins showed extensive colocalization
with this EGFR-containing compartment, supporting our
hypothesis that the EGFR-containing vesicles accumulate
in the exocytic and not in the endocytic pathway
(Figure S4). Interestingly, also the delivery of β1-integrin
towards the front of the cell is affected in myosin VI or
optineurin KD cells (Figure S5).
As polarized delivery into the leading edge is also
dependent on Golgi positioning, we investigated whether
Golgi reorientation towards the wound is affected
in myosin VI or optineurin KD cells. In A549 cells,
1.5–2 h after wounding 80% of the Golgi complexes
are repositioned to face the wound edge and reduction
in myosin VI or optineurin expression does not result in
a significant defect in Golgi reorientation in the KD cells
(Figure 6B).
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Figure 6: Depletion of myosin VI or optineurin does not
affect steady-state cell surface levels of EGFR or Golgi
reorientation. A) The steady-state surface levels of EGFR in
control and myosin VI or optineurin knockdown A549 cells
were analysed by FACS as described in Materials and Methods.
The graph shows the ratio of surface to total antigen for each
condition. Values shown are means± SD from three independent
siRNA experiments. B) To assess Golgi reorientation towards the
wound, siRNA-treated A549 cells were scratched, fixed after
2 h and processed for immunofluorescence with antibodies to
GM130. Cells with Golgi repositioned to face the wound were
counted. Values shown are means ± SD from five independent
siRNA experiments.
Loss of myosin VI or optineurin does not affect
random cell migration
To determine whether myosin VI or optineurin depletion
has any effect on random single cell migration in an
isotropic environment, A549 cells were plated onto
fibronectin-coated glass chambers, time-lapse videos
collected and the movements of individual cells were
followed using tracking software. The tracks of 3434
control cells, 2577 myosin VI siRNA-treated cells and 1950
optineurin siRNA-treated cells were analysed. Still images
of time-lapse microscopy videos of control or siRNA-
treated A549 cells with migration tracks superimposed
onto the original image sequences are shown in
Figure 7A. Measuring the individual trajectories of the cell
centroids and subsequent analysis of the cell movements
showed that myosin VI or optineurin depletion results
in an increase in the average diffusion coefficient from
0.72 ± 0.02 (control cells) to 1.08 ± 0.03 μm2/min (myosin
VI KD cells) and 1.21 ± 0.05 μm2/min (optineurin KD
cells), which corresponds to the steeper mean-squared
displacement (MSD) curves shown in Figure 6. Both
myosin VI (0.72 ± 0.04 μm/min) and optineurin KD cells
(0.48 ± 0.01 μm/min) move faster with higher velocity as
compared with control cells (0.37 ± 0.01 μm/min). These
results indicate that the loss of myosin VI or optineurin
does not affect the basic ability of cells to perform random
movements. On the contrary, myosin VI and optineurin KD
cells show an increase in non-directional random motility
(Figure 7).
Myosin VI and optineurin are required
for chemotactic migration
The directed movement of cells is dependent on spatially
restricted receptor tyrosine kinase signalling. As the
polarity of EGFR localization is lost in myosin VI and
optineurin KD cells, we tested the ability of myosin VI or
optineurin KD cells to migrate towards a chemotactic
stimulus using a Transwell migration assay. SiRNA-
treated A549 cells were plated in the upper chambers
of Transwells and the lower chambers were filled with
medium with or without 20 ng/mL of EGF. In the absence
of EGF, the number of control cells that had migrated
after 5 h to the underside of the filter was similar to the
number of myosin VI or optineurin KD cells. However,
in the presence of EGF in the lower chamber, control
cells responded with a fivefold increase in the number of
cells migrating towards a chemotactic gradient, whereas
in myosin VI or optineurin-depleted cells only a 2.5-fold or
2.8-fold increase in migration was observed (Figure 8A,B).
These results indicate that both myosin VI and optineurin
are required to sustain directed migration towards a
chemotactic stimulus, and the mechanism involved is
the polarized trafficking of membrane components into
the leading edge of the cell.
Discussion
We have shown that myosin VI and its interacting protein
optineurin are essential for directed cell migration in
mammalian cells. The loss of either optineurin or myosin
VI inhibits the delivery of EGFR to the leading edge
at the front of the cell and causes a dramatic defect
in lamellipodia formation. Surprisingly, this does affect
random migration of myosin VI or optineurin KD cells;
however, both proteins are crucial for cells to perform
directed migration towards a chemotactic gradient. As
optineurin has been shown to mediate the function of
myosin VI in post-Golgi membrane transport, our results
indicate that the role of myosin VI in cell motility is linked
to anterograde membrane trafficking pathways.
Numerous lines of evidence now suggest that in a
motile polarized cell plasma membrane proteins are
delivered into the leading edge in an anterograde direction
from the Golgi complex and/or the endocytic recycling
pathway. In this process, directed secretion towards
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Figure 7: Depletion of myosin VI
or optineurin leads to changes
in random cell migration. To anal-
yse the randommigration behaviour
of A549 cells, we used time-
lapse microscopy to capture the
movements of individual cells on
fibronectin-coated glass. A) Ran-
domly selected fields of migra-
tion tracks of control, myosin VI
or optineurin siRNA-treated cells
tracked for 5 h. Bar, 100 μm. B)
MSD of cells calculated from XY
coordinates over time. The migra-
tion tracks of 3434 control, 2577
myosin VI and 1950 optineurin
KD cells were analysed combined
from four (for myosin VI) or three
(for optineurin) independent siRNA
experiments. Error bars represent
SD. The table represents the diffu-
sion coefficients (Dlat ± SD) calcu-
lated from MSD curve fitting.
the wound edge is dependent on Golgi positioning;
however, very little is known about the other constituents
of the machinery responsible for polarized delivery into
the leading edge. Interestingly, in neither myosin VI or
optineurin KD cells was a defect in Golgi reorientation
towards the wound observed, indicating that myosin VI
and optineurin are not involved in this process, but are
most likely involved in polarized post-Golgi transport or
sorting steps. Furthermore, as cdc42 is the key regulator
of cell polarity and Golgi reorientation, our results suggest
that myosin VI and optineurin are not major players in
this cdc42-dependent signalling pathway. This hypothesis
is supported by the finding that depletion of functional
myosin VI and optineurin leads to a reduction of Rac-
dependent lamellipodia but to an increase in finger-like
protrusions known as filopodia, which in most cell types
are formed after cdc42 activation. This replacement of
broad lamellipodia and ruffles with finger-like filopodia can
be observed both in myosin VI-depleted cells in scratch
wound assays of cell monolayers (Figure 1) and also during
single cell spreading in GFP-myosin VI tail-expressing cells.
Interestingly, these dramatic morphological changes do
not result in changes in the speed of spreading of myosin
VI-depleted cells (data not shown).
In epithelial cells, distinct pathways for the selective sort-
ing of cargo leaving the trans Golgi network to either the
apical or basolateral cell surface have been described. In
polarized MDCK cells, we have shown a role for myosin
VI and optineurin in the selective sorting of cargo such
as vesicular stomatitis virus glycoprotein (VSV-G) to the
basolateral domain (22). In a motile fibroblast, VSV-G is
targeted to the leading edge (35), suggesting that similar
pathways and machinery used for delivery of proteins to
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Figure 8: Myosin VI and optineurin are required for directed migration towards an EGF gradient. SiRNA-treated A549 cells were
starved and plated into the upper chambers of Transwells in serum-free medium and the same medium with or without 20 ng/mL EGF
was added to the lower well. After 5 h the cells were fixed, stained and the cells on the under surface were counted. A) A representative
experiment showing the number of control and myosin VI or optineurin siRNA-treated cells migrated under basal (light grey bars) and
EGF-stimulated (dark grey bars) conditions. B) Chemotactic response to EGF. The graphs represent the fold increase in migration,
calculated as a ratio of the number of cells migrated to the under surface of the membrane upon EGF stimulation to the number of cells
migrated under basal conditions. Values shown are means ± SD from three independent siRNA experiments.
the basolateral domain are also required for targeting of
proteins to the leading edge in motile cells. Interestingly
in neurons, trafficking in the biosynthetic pathway is also
targeted to distinct subdomains of the plasma membrane,
e.g. to the dendritic surface of the cell body, which is
similar to the basolateral domain and to the axonal mem-
brane, which can be regarded as analogous to the apical
domain of MDCK cells (24). Thus, in hypocampal neurons,
exocytic trafficking of AMPA (α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid) receptor to the postsynaptic
membrane at the somatodendritic cell surface, the baso-
lateral analogue, has been shown to require myosin
VI (33). These observations give further support to our
observations that a complex of myosin VI and optineurin
drives the local delivery of EGFR into the leading edge of
a motile cell at the wound edge.
Previously, myosin VI and optineurin have been linked
to constitutive exocytosis of reporter molecules such as
secreted alkaline phosphatase (SEAP) and VSV-G; deple-
tion of either myosin VI or optineurin resulted in a kinetic
delay in delivery of the reporters to the cell surface (14,21).
In this study, we show that the steady-state surface lev-
els of endogenous transmembrane proteins, such as the
EGFR, are not affected in myosin VI or optineurin KD cells.
The absence of myosin VI or optineurin, however, dramat-
ically impairs the selective delivery of these membrane
proteins into the leading edge. These results indicate
that myosin VI and optineurin are required for the spatial
delivery of membrane proteins in the anterograde traf-
ficking pathway, but are not essential for steady-state
secretion of every cargo to the plasma membrane. Trans-
membrane proteins are either delivered directly from the
Golgi complex to the plasma membrane or via an inter-
mediate recycling endosome. In polarized epithelial cells,
myosin VI and optineurin are present on a specialized recy-
cling compartment, a sorting station for proteins delivered
to the basolateral domain (22). In epithelial cells, cargo
en route to the basolateral domain can pass through
a possibly specialized type of recycling endosome, and
also in macrophages this type of organelle is important
for polarized secretion of cytokines (36). This proposed
role of myosin VI and optineurin in anterograde trafficking
pathways, which include the route from the recycling com-
partment to the plasma membrane, is supported by our
finding that polarized delivery of β1-integrin towards the
cell front is also affected in myosin VI or optineurin A549
KD cells (Figure S5). Future work will confirm whether the
myosin VI-dependent delivery of the EGFR to the leading
edge involves a sorting step in a recycling compartment,
whereas transport to the rest of the plasma membrane
proceeds directly from the trans Golgi network and there-
fore may not be dependent on myosin VI.
Interestingly, the absence of myosin VI or optineurin,
which leads to a dramatic reduction in lamellipodia
formation at the leading edge, does not lead to defects in
random cell migration. In contrast, myosin VI or optineurin-
depleted cells show an increase in motility, which is
reflected in an increase in MSD as well as the velocity
over time. Although it seems surprising that myosin VI and
optineurin KD cells with less lamellipodia show increased
random migration, this is not a new observation. In
epithelial PtK1 cells, non-muscle tropomyosin inhibition
causes a loss of lamellipodia, but a dramatic increase in
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randommigration velocity (37), supporting our observation
that indeed cells can migrate without a lamellipodium.
Although myosin VI or optineurin KD cells do not lack
the ability to move, they are impaired in performing
directed migration towards a stimulus gradient. This type
of movement requires a signal perceived and amplified in a
restricted area at the front of the cell. Although a polarized
concentration of signalling receptors at the leading edge
is not required in all cell types for chemotaxis (38), we
clearly observed an accumulation of EGFR in the plasma
membrane of protrusions at the front of A549 cells close
to the coverslip using confocal microscopy. Therefore,
we believe that the polarized localization of EGFR at the
leading edge of A549 cells enhances localized signalling
at the front, which is important for directed migration (39).
Polarized secretion has also been shown in migrating
fibroblasts, where secretory vesicles are preferentially
delivered and inserted at the leading edge (7).
Our results are consistent with previous work in
Drosophila that implicated myosin VI in epithelial cell
migration required for dorsal closure during embryoge-
nesis (10) and in border cell migration in oocytes (11). In
these border cells, inhibition of myosin VI also leads to
a reduction in protrusion formation at the leading edge.
From Drosophila oocytes, myosin VI can be isolated in a
complex with Drosophila E-cadherin and it was therefore
proposed thatmyosin VI promoted protrusion formation by
moving towards the minus end of the polymerizing actin
filaments while binding to a stationary E-cadherin complex
and thereby pushing the actin filaments into the leading
edge. At present, we cannot exclude this role formyosin VI
in protrusion formation in mammalian cells; however, we
did not observe any association of myosin VI with focal
adhesion complexes at the leading edge in A549 cells
or any other defects in focal adhesion formation or cell
spreading in myosin VI-depleted cells. Our results, how-
ever, are supported by data showing that although vinculin
is a downstream effector of myosin VI at E-cadherin-
dependent cell–cell contact sites, no changes or defects
at integrin-based cell-matrix adhesion sites were observed
upon myosin VI depletion (15). In contrast, a recent study
indicates that in endothelial cells myosin VI and its
interacting protein GIPC are important for α5β1 integrin
endocytosis and that the absence of either protein causes
defects in cell adhesion (20). These different results sug-
gest that there are probably cell-specific variations in the
involvement of myosin VI in cell adhesion formation.
In addition, we cannot exclude a role for myosin VI in
actin filament reorganization at the leading edge, although
so far no interacting protein directly linking myosin VI
to the machinery regulating actin filament dynamics has
been identified in mammalian cells. However, we have
previously shown the recruitment of myosin VI into the
leading edge after EGF stimulation (28). Furthermore, in
Drosophila myosin VI has been shown to stabilize actin
filaments required for spermatid individualization (40).
Therefore, future work is required to show whether
myosin VI coordinates membrane delivery and actin
organization at the leading edge.
In summary, we have clearly shown that myosin VI
together with the adaptor protein optineurin is required
for the delivery of specific cargo such as the EGFR in
the anterograde pathway towards the front of a migrating
cell. This delivery is essential for protrusion formation at
the leading edge of the cell and for the generation of
directionally persistent migration.
Materials and Methods
Plasmid constructs and antibodies
Constructs coding for GFP-tagged full-length human myosin VI and the
tail domain were described previously (19,29). To generate constructs
for stable expression, GFP-MyoVI and GFP-tail fusion cassettes were
subcloned from pEGFPC3 into the pIRESneo2 vector (Clontech).
The following commercial antibodies were used: rabbit polyclonal
antibodies to GFP (Molecular Probes), mouse monoclonal antibodies to
GM130 (BD Transduction Laboratories) and β1 integrin (P5D2; Santa
Cruz), α-tubulin (Sigma); 13A9 monoclonal to EGFR was kindly provided
by Genentec. Antibodies to myosin VI and optineurin were previously
described (21,28).
Cell culture, transfection and siRNA
HeLa cells were cultured in RPMI-1640 and A549 in DMEM, containing
10% FCS, 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL
streptomycin, and transfected using FuGENE (Roche Diagnostics),
according to the manufacturer’s instruction. To generate GFP-MyoVI
and GFP-tail stably expressing cell lines, HeLa cells were transfected
with corresponding constructs in pIRESneo2 and selected with complete
medium containing 500 μg/mL G418 (Gibco). All stable clones were
combined for each construct and the cells were FACS sorted to enrich for
highly expressing cells.
All siRNA oligos were obtained from Dharmacon. ON-TARGETplus smart
pool as well as single ON-TARGETplus oligos (19) were used to KD myosin
VI. ON-TARGETplus smart pool and a single duplex (21) were used for
depletion of optineurin. Smart pool and single oligos yielded similar levels
of KD and the same phenotypes. ON-TARGETplus smart pool were used
for KD of GIPC and Dab2, single duplex 2068 (19) was used for KD of
LMTK2, a non-targeting oligo was used as a control. For efficient KD,
HeLa and A549 cells were transfected twice with siRNA on day 1 and
3 using Oligofectamine (Invitrogen). On day 5, cells were processed for
corresponding assays and the efficiency of protein depletion was assessed
by western blotting.
Immunofluorescence
HeLa cells growing on coverslips were transfected with corresponding
plasmids and 24 h later were fixed with 4% paraformaldehyde (PFA),
permeabilized with 0.1% Triton-X-100, blocked with 1% BSA in PBS
and processed for indirect immunofluorescence using primary antibodies
(specified in the figure legends) and secondary antibodies coupled with
Alexa 488 or Alexa 568 and Alexa 568-labelled phalloidin (Molecular
Probes).
For scratch wound assays, siRNA-treated HeLa or A549 cells, or HeLa cells
stably expressing GFP-myosin VI or GFP-tail, were plated on coverslips at
high density and 24 h later scratched with a pipette tip. The cells were
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incubated in growth medium and fixed after 2 h (HeLa) or after 1 h (A549)
and processed for immunofluorescence as described earlier.
For macropinocytosis assay, siRNA-treated A549 cells were plated on
coverslips at low density and next day were starved for 6 h and loaded with
0.5 mg/mL of 70-kDa tetramethylrhodamine-coupled lysine-fixable dextran
(Molecular Probes) for 30 min in the presence of 20 ng/mL EGF, then
fixed and mounted for microscopy. The cells were visualised with a Zeiss
Axioplan epifluorescence microscope equipped with 63×/1.4 numerical
aperture (NA) objective and a Hamamatsu ORCA-R2 charge-coupled device
(CCD) camera driven by SIMPLE PCI software. Alternatively, Zeiss LSM-510
confocal microscope (Carl Zeiss MicroImaging Inc.) was used. Images
were processed in Adobe Photoshop and assembled in Adobe Illustrator.
Immunoblotting
Cells were lysed in SDS–PAGE sample buffer and the lysates were
analysed by SDS–PAGE followed by immunoblotting using standard
protocol. Blots were developed using ECL detection reagent (GE
Healthcare).
Live-cell imaging and analysis of membrane
dynamics
A549 cells growing on coverslips werewoundedwith a pipette tip, washed
and left to recover at 37◦C in CO2-independent medium supplemented
with 10% FCS. Time-lapse videos were acquired between 1 and 2 h
after wounding using a Zeiss Axiovert 200M microscope equipped with
a heated stage, 60× oil phase-contrast objective and a Photometrics
Cool Snap CCD camera (Roper Scientific) driven by OPENLAB software
(Improvision). Images were captured with 2- or 5-second intervals. The
dynamics of lamellipodial extensionswas analysed using VOLOCITY software
(Improvision). Kymographs were created from time-lapse sequences and
the following parameters were calculated: maximum height of individual
peaks (corresponding to lamellipodia length), maximum width of individual
peaks (corresponding to lamellipodia lifetime) and the slope of the
ascending contours (corresponding to protrusion velocity).
Flow cytometry
Steady-state surface and total EGFR and β1 integrin levels were measured
by flow cytometry. A549 cells were detached using non-enzymatic cell
dissociation solution (Invitrogen), pelleted by centrifugation, washed with
medium, cooled down on ice and incubated with antibodies to EGFR or β1
integrin on ice for 30 min. Unbound antibodies were washed off with ice-
cold PBS, the cells were then fixed in 4%PFA for 20 min and permeabilized
with 0.1% Triton-X-100 in PBS for 5 min at room temperature. At this point,
each sample was split into two, one half (representing surface amount
of the antigen) was incubated with Alexa 488-conjugated goat anti-mouse
secondary antibody for 30 min at room temperature and the second half
(representing total amount of the antigen) was incubated again with the
corresponding primary and then with secondary antibody. Cell-associated
Alexa 488 fluorescence was determined using BD FACSCalibur flow
cytometer (BD Biosciences). Cells labelled with secondary antibody only
were used as negative controls in each experiment. All experiments were
performed in duplicates and repeated three times. Mean fluorescence
intensity was calculated using FLOWJO software.
Migration assays
To assess random migration, A549 cells were labelled with 5 μM of Cell
Tracker CMRA (Invitrogen) for 30 min according to the manufacturer’s
instructions. Labelled cells were dissociated using accutase (PAA
Laboratories) and resuspended in DMEM supplemented with 10% FCS,
glutamine and 10 mM HEPES. The cells were plated onto a fibronectin-
coated coverglass system (chambered 1.0 borosilicate; Lab-Tek) at a
density of 20 000 cells/cm2 and left in the incubator for 2 h before time-
lapse analysis. Cells were visualized using an RT live-imaging workstation
(Deltavision; Applied Precision, LLC) and an Olympus IX-70 microscope
equipped with a CCD camera (Micromax 1300 YHS; Roper Scientific)
in a heated environmental chamber (37◦C, 5% CO2). Images of cells
were taken with 4×/0.13 NA objective and Rhodamine-Texas Red
filter set (Chroma Technology Corp.) with 2-min intervals for 4 h using
SOFTWORX acquisition software (Applied Precision, LLC). Myosin VI or
optineurin siRNA-treated cells were imaged simultaneously with controls;
3434 control, 2577 MyoVI and 1950 optineurin siRNA cell tracks were
analysed combined from four (for myosin VI) or three (for optineurin)
independent siRNA KD experiments. Measurement of XY coordinates
of cells centroids and subsequent analysis of cell movement were
performedusing single particle tracking algorithm in GMIMPRO software (41),
http://www.nimr.mrc.ac.uk/gmimpro/. MSD of cells was calculated using
overlapping intervals. The cell speed was calculated by fitting the MSD
data into the random walk equation.
For Transwell migration assays, 24-well Falcon chambers with 8-μm pore
membrane (Beckton Dickinson Labware) were used. Both sides of the
membrane were coated with 10 μg/mL collagen I (Sigma). A549 cells
were starved overnight and seeded to the upper chambers at a density of
1 × 105/well in DMEM containing 0.1% BSA. The same medium with or
without 20 ng/mL EGF was added to the lower well and the cells were
allowed tomigrate for 5 h at 37◦C. At the end of the assay, the insertswere
fixed and stained using Hema Gurr rapid staining set (BDH), cells from the
upper surface were removed with a cotton swab and the cells migrated
to the under surface were counted under low magnification. At least 10
independent fields were counted for each membrane, all experiments
were performed in duplicates and repeated three times.
Statistical analysis
Statistical evaluations were performed using two-sample Kolmogorov–
Smirnov tests calculated in statistical package R (http://www.r-project.org).
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Supporting Information
Additional Supporting Information may be found in the online version of
this article:
Figure S1: Lamellipodia formation in A549 cells. A) To assess
lamellipodia formation, A549 cells were transfected with control siRNA,
siRNA specific for Rab8 or for double knockdowns with siRNA specific for
myosin VI and optineurin, for Dab2 and GIPC, for LMTK2 and Dab2 or for
LMTK2 and GIPC. The wound healing assay was performed as described
in Figure 3. The graph shows a representative experiment presenting the
percentage of cells that extend large lamellipodia into the wound. B)
Western blot of siRNA knockdown experiment using antibodies to LMTK2,
myosin VI, Dab2, optineurin, GIPC and Rab8.
Figure S2: Loss of myosin VI or optineurin causes accumulation of
EGFR-containing vesicles. A549 cells were transfected with control
siRNA or siRNA specific to myosin VI or optineurin. A confluent layer of
cells was wounded, fixed after 1 h when maximal protrusion formation
was observed and stained with a monoclonal antibody to EGFR and
fluorescently labelled phalloidin to label F-actin. Merged colour widefield
images are shown in the right-hand panel. Bar, 10 μm.
Figure S3: EGFR-positive vesicles are only partially labelled after
endocytosis of fluorescently labelled EGF. A549 cells were transfected
with control siRNA or siRNA specific to myosin VI or optineurin and
incubated with 250 ng/mL Alexa 488-labelled EGF for 10 min before fixing
and staining with the monoclonal antibody to EGFR. The images presented
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are widefield. The merged colour images are shown in the right-hand
panel. Bar, 10 μm.
Figure S4: EGFR-containing vesicles do not colocalize with marker
proteins of the endocytic pathway. A549 cells were transfected with
control siRNA or siRNA specific to myosin VI. After fixation, the cells were
double labelled with the monoclonal antibody to the EGFR and different
marker proteins of the endocytic pathway: cathepsin D to label lysosomes,
mannose-6-phosphate receptor (M6PR) to label late endosomes and vps26,
a component of the mammalian retromer complex, which is present on
early and late endosomes. Bar, 10 μm.
Figure S5: Myosin VI and optineurin are required for targeting of
β1-integrin to the plasma membrane facing the wound. A) A549
cells were transfected with control siRNA or siRNA specific to myosin
VI or optineurin. The cells were grown to confluence, wounded, left to
recover for 1 h, then fixed and processed for immunofluorescence with
monoclonal antibody to β1-integrin and fluorescently labelled phalloidin to
label F-actin. Merged colour images are shown in the right-hand panel.
The images presented are confocal slices through the base of the cells.
B) The steady-state surface levels of β1-integrin in control and myosin VI
or optineurin knockdown A549 cells were analysed by FACS as described
in Materials and Methods. The graph shows the ratio of surface to total
antigen for each condition. Values shown are means ± SD from three
independent siRNA experiments. Bar, 10 μm.
Video S1: Time-lapse phase-contrast video of control siRNA-treated
A549 cell at the wound edge. Images were taken every 2 seconds for
8.5 min.
Video S2: Time-lapse phase-contrast video of myosin VI-depleted A549
cell at the wound edge. Images were taken every 2 seconds for 8.5 min.
Please note: Wiley-Blackwell are not responsible for the content or
functionality of any supporting materials supplied by the authors.
Any queries (other than missing material) should be directed to the
corresponding author for the article.
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